Corrado Advisors, LLC Gilead Sciences, Inc. Transaction History

Corrado Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$62.32 - $89.47 $91,922 - $131,968	1,475 New	1,475 $126,000
Q1 2018 Apr 06, 2018	SELL	$72.84 - $88.8 $3.49 Million - $4.26 Million	-47,976 Closed	0 $0
Q4 2017 Jan 10, 2018	SELL	$71.15 - $83.52 $163,289 - $191,678	-2,295 Reduced 4.57%	47,976 $3.44 Million
Q3 2017 Oct 06, 2017	BUY	$72.11 - $85.47 $3.63 Million - $4.3 Million	50,271	50,271 $4.07 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Corrado Advisors, LLC with notifications on news.